Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Clinical and Experimental Immunology
|
May 2, 2002
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
A R Kitching, M Katerelos, S J Mudge, et al.
Drug Development and Industrial Pharmacy
|
April 29, 1999
Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis
M J D'Souza, C W Oettinger, A Shah, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits
J H Erlich, J Apostolopoulos, T C Wun, et al.
Kidney International
|
April 14, 1999
Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis
M A Cunningham, T Ono, T D Hewitson, et al.
American Journal of Physiology. Renal Physiology
|
November 13, 2001
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice
A F Drew, H L Tucker, H Liu, et al.
Clinical and Experimental Immunology
|
July 1, 1997
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats
X R Huang, P G Tipping, J Apostolopoulos, et al.
British Journal of Rheumatology
|
June 1, 1988
Detection of anti-DNA antibodies: a comparison between two Farr assays, Crithidia luciliae and a human chromosomal substrate assay
P G Tipping, R R Buchanan, A G Riglar, et al.
Pathology
|
January 1, 1991
Measurement of anti-DNA antibodies by ELISA: a comparative study with Crithidia and a Farr assay
P G Tipping, R C Buchanan, A G Riglar, et al.
Clinical Science (London, England : 1979)
|
June 21, 2001
Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII
R E Peverill, H J Teede, J J Smolich, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
A R Kitching, S R Holdsworth, V A Ploplis, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Clinical and Experimental Immunology
|
May 2, 2002
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
A R Kitching, M Katerelos, S J Mudge, et al.
Drug Development and Industrial Pharmacy
|
April 29, 1999
Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis
M J D'Souza, C W Oettinger, A Shah, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits
J H Erlich, J Apostolopoulos, T C Wun, et al.
Kidney International
|
April 14, 1999
Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis
M A Cunningham, T Ono, T D Hewitson, et al.
American Journal of Physiology. Renal Physiology
|
November 13, 2001
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice
A F Drew, H L Tucker, H Liu, et al.
Clinical and Experimental Immunology
|
July 1, 1997
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats
X R Huang, P G Tipping, J Apostolopoulos, et al.
British Journal of Rheumatology
|
June 1, 1988
Detection of anti-DNA antibodies: a comparison between two Farr assays, Crithidia luciliae and a human chromosomal substrate assay
P G Tipping, R R Buchanan, A G Riglar, et al.
Pathology
|
January 1, 1991
Measurement of anti-DNA antibodies by ELISA: a comparative study with Crithidia and a Farr assay
P G Tipping, R C Buchanan, A G Riglar, et al.
Clinical Science (London, England : 1979)
|
June 21, 2001
Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII
R E Peverill, H J Teede, J J Smolich, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
A R Kitching, S R Holdsworth, V A Ploplis, et al.
Page
of 7